Thu, 18-Aug-2022

Lung Cancer

Pharma and Biotech Companies Performing Strategic Ac...

Since past few years, global healthcare is consistently working on cancer treatments. Various common and rare cancer cases are being detected and this disease is killing patients due to unavailability of effic... August 14, 2020 2:37 pm By Neha Mule

Daiichi Sankyo and Gustave Roussy Enter Innovative R...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Gustave Roussy today announced a multi-year, multi-study research collaboration to enrich and further enable the development of DS-1062 and patri... July 22, 2020 12:08 pm By Neha Mule

Innovent Announces the NMPA Granted Marketing Approv...

Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that BYVAS... June 19, 2020 11:31 am By Neha Mule

VUNO Med LungCT AI Receives MFDS Regulatory Approval

VUNO, a member company of the Born2Global Centre, announced that the first CT based pulmonary nodule detecting AI solution in Korea, “VUNO Med-LungCT AI”, was approved by the Ministry of Food and Drug S... April 29, 2020 8:22 am By Neha Mule

Pulmatrix Announces Kinase Inhibitor Licensing Agree...

Pulmatrix, Inc. today announced that it has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson (J&J).  Through the agreement, the Lung Cancer Initiative g... January 2, 2020 2:15 pm By Neha Mule

Related News